Addition of parsaclisib (INCB050465), a PI3Kd inhibitor, in patients with suboptimal response to ruxolitinib: A phase 2 study in patients with myelofibrosis
Parsaclisib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Addition of parsaclisib (INCB050465), a PI3Kd inhibitor, in patients with suboptimal response to ruxolitinib: A phase 2 study in patients with myelofibrosis ### Output: Parsaclisib